Rotam establishes Korean subsidiary

In keeping with its progressive strategy on emerging markets, Rotam CropSciences, headquarted in Hong Kong, has announced its Korean operations will now become a wholly owned company, directly servicing dealers where the registered products had been reaching the customers through a number of local agrochemical formulation and sales companies. Having extended its product portfolio, Rotam established Rotam LifeSciences Korea Limited in the international business hub, Gangnam district in Seoul. This move allows Rotam to more efficiently serve the local market, working closer to customers on new product launches and improving level of technical support.

“We are very optimistic about the potential growth in Korea,” says Danny Shen, Senior Manager, Emerging Areas.  “Moving from the formulator / distributor level down to the dealer level allows us to more completely serve this emerging market, which is growing quickly in terms of the demand for qualified and advanced formulation products with reasonable market price.”

Rotam Has The Competitive Advantage

With its strong production base in China supported by solid research and development, the new positioning will allow for the distribution of higher quality products within Rotam’s diverse crop input portfolio. It will also create a deeper engagement at the local dealer level, allowing Rotam to quickly and efficiently address market needs.

“Rotam is well positioned to expand in Korea, offering a number of advantages for customers.” Shen says. “We have a reputation for quality in the market with well established products like Tantan® and Romectin®. In addition, we have an excellent added-value and differentiated pipeline that is now rolling out providing a wide and deep crop protection solutions in Korea.

Shen concludes that Rotam will be one of the very few foreign companies in Korea having a broad product portfolio with more than 20 registrations.